119th Congress
H.R. 3493
Global Fairness in Drug Pricing Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Ro Khanna(D-CA)
- Introduced
- May 19, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on the Judiciary; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (7)
Original cosponsors (3)
- Andy Biggs (R-AZ)
- Anna Paulina Luna (R-FL)
- Marcy Kaptur (D-OH)
Added later (4)
- Elijah Crane (R-AZ) · Jun 3, 2025
- G000596 · Oct 17, 2025
- Suhas Subramanyam (D-VA) · Nov 7, 2025
- Tom Barrett (R-MI) · Feb 24, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To reduce prescription drug prices by aligning U.S. prices with international benchmarks.
Latest action(May 19, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Roll-call votes
No recorded votes on this bill.
Actions
- May 19, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - May 19, 2025
Introduced in House